In addition to LC screening, high levels of MUC1, CA125, KL-6, CYFRA21-1, and LAMC2 also predict the overall survival of NSCLC patients, thereby demonstrating the prognostic implications of mucins in NSCLC [107,108]. This evidence concerns the gene MUC16 and non-small cell lung carcinoma.